Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of Investigative Dermatology

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/1523-1747.EP12337492PMID 9326393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen

  2006cited by this paper
• A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex.

  1997cited by this paper
• Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida.

  1997cited by this paper
• Demonstration of the Molecular Shape of BP180, a 180-kDa Bullous Pemphigoid Antigen and Its Potential for Trimer Formation*

  1996cited by this paper
• Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain.

  1996cited by this paper
• Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain.

  1995cited by this paper
• An animal model of bullous pemphigoid: what can it teach us?

  1995cited by this paper
• Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1.

  1995cited by this paper
• Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid.

  1995cited by this paper
• Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin

  1995cited by this paper
• Autoimmune response against the bullous pemphigoid 180 autoantigen.

  1994cited by this paper
• Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen.

  1994cited by this paper
• Human monoclonal autoantibodies specific for the bullous pemphigoid antigen 1 (BPAg 1).

  1994cited by this paper
• Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis.

  1994cited by this paper
• Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein.

  1993cited by this paper
• Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

  1993cited by this paper
• A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.

  1993cited by this paper
• Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.

  1993cited by this paper
• IgG antibodies from patients with bullous pemphigoid bind to fusion proteins encoded by BPAg1 cDNA.

  1993cited by this paper
• Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain.

  1993cited by this paper
• Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180.

  1992cited by this paper
• Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization.

  1992cited by this paper
• Autoantibodies in pathology and cell biology.

  1991cited by this paper
• Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180.

  1991cited by this paper
• Production of rabbit antibodies against carboxy-terminal epitopes encoded by bullous pemphigoid cDNA.

  1990cited by this paper
• A soluble and immunoreactive fragment of pemphigus foliaceus antigen released by trypsinization of viable human epidermis.

  1990cited by this paper
• IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA.

  1990cited by this paper
• Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome.

  1990cited by this paper
• The polymerase chain reaction. A new method of using molecular genetics for medical diagnosis.

  1990cited by this paper
• Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies.

  1988cited by this paper
• Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

  1988cited by this paper
• Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction.

  1986cited by this paper
• Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting.

  1985cited by this paper
• Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia.

  1981cited by this paper

• Peptide Epitopes of NC16A BP180 in the Diagnostics of Bullous Pemphigoid

  2025cites this paper
• UNDERSTANDING THE PHYSIOLOGICAL MECHANISMS OF BULLOUS PEMPHIGOID

  2025cites this paper
• Autoimmune bullous diseases: pathogenesis and clinical management

  2025cites this paper
• Eosinophil-derived neurotoxin and eosinophil cationic protein are key molecules for blister formation in bullous pemphigoid.

  2025cites this paper
• Bullous pemphigoid

  2025cites this paper
• Diagnostic challenge: Juvenile bullous pemphigoid with a negative BP180 ELISA

  2024cites this paper
• Anti-NC16A IgA from linear IgA bullous dermatosis patients induce neutrophil-dependent subepidermal blistering in mice.

  2023cites this paper
• DISEASE ENDOTYPES PREDICT SEVERITY OF MUCOUS MEMBRAND PEMPHIGOID.

  2023cites this paper
• A life for autoimmune blistering diseases: in memoriam Detlef Zillikens

  2023cites this paper
• Research progress of omalizumab in the treatment of bullous pemphigoid

  2023cites this paper
• The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid.

  2023cites this paper
• Pemphigoiderkrankungen bei älteren Menschen

  2023cites this paper
• Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients’ Assessment

  2022cites this paper
• CCID_A_267573 661..673

  2022cites this paper
• Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders

  2022cites this paper
• The relevance of complement in pemphigoid diseases: A critical appraisal

  2022cites this paper
• Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid

  2022cites this paper
• What's new in the pathogeneses and triggering factors of bullous pemphigoid

  2022cites this paper
• Current approaches to the diagnosis of autoimmune bullous dermatoses

  2021cites this paper
• The impact of lesional inflammatory cellular infiltrate on the phenotype of bullous pemphigoid

  2021cites this paper
• Intraepithelial Autoimmune Blistering Dermatoses: Clinical Features and Diagnosis.

  2021cites this paper
• Subepidermal Autoimmune Blistering Dermatoses: Clinical Features and Diagnosis.

  2021cites this paper
• The pathogeneses of pemphigus and pemphigoid diseases.

  2021cites this paper
• Collagen XVII Processing and Blistering Skin Diseases

  2020cites this paper
• The role of Dipeptidyl Peptidase‐4 in cutaneous disease

  2020cites this paper
• Emerging treatments for bullous pemphigoid

  2020cites this paper
• International validation of the Bullous Pemphigoid Disease Area Index severity score and calculation of cut‐off values for defining mild, moderate and severe types of bullous pemphigoid *

  2020cites this paper
• The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures

  2020cites this paper
• Non–Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice

  2020cites this paper
• B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid

  2019cites this paper
• Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models

  2019cites this paper
• Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180‐NC16A‐specific IgG antibodies in bullous pemphigoid

  2019cites this paper
• Serological Diagnosis of Autoimmune Bullous Skin Diseases

  2019influential citation
• Lichen Planus Pemphigoides Mimicking Toxic Epidermal Necrolysis.

  2019cites this paper
• Type XVII collagen

  2019cites this paper
• Intravenous IgG Reduces Pathogenic Autoantibodies, Serum IL-6 Levels, and Disease Severity in Experimental Bullous Pemphigoid Models

  2019cites this paper
• Reorganization of serum analysis tools for the diagnosis of bullous pemphigoid

  2019cites this paper
• Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics

  2019cites this paper
• Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid

  2019cites this paper
• The pathogenesis of bullous skin diseases

  2019cites this paper
• Type VII collagen IgE autoantibodies in epidermolysis bullosa acquisita: more common than suspected

  2019cites this paper
• Demographics and Autoantibody Profiles of Pemphigoid Patients with Underlying Neurologic Diseases.

  2019cites this paper
• Adjuvante Behandlung des schweren/refraktären bullösen Pemphigoids mit Protein‐A‐Immunadsorption

  2018cites this paper
• Adjuvant treatment of severe/refractory bullous pemphigoid with protein A immunoadsorption

  2018cites this paper
• University of Groningen Cold cases in epidermolysis bullosa: not the usual suspects Turcan, Iana

  2018cites this paper
• Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation

  2018cites this paper
• Humoral Epitope Spreading in Autoimmune Bullous Diseases

  2018cites this paper
• Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations

  2018cites this paper
• Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse

  2018cites this paper
• Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody

  2018influential citation
• Tissue Destruction in Bullous Pemphigoid Can Be Complement Independent and May Be Mitigated by C5aR2

  2018cites this paper
• Diagnosis of Autoimmune Blistering Diseases

  2018cites this paper
• Bullous Pemphigoid Bullous Pemphigoid

  2018influential citation
• Chapter 17 – Inflammation in Bullous Pemphigoid, a Skin Autoimmune Disease

  2018cites this paper
• Cold cases in epidermolysis bullosa: not the usual suspects

  2018cites this paper
• Intravenous IgG Reduces Pathogenic Autoantibodies, Serum IL-6 Levels, and Disease Severity in Experimental Bullous Pemphigoid Models.

  2018cites this paper
• Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment

  2017cites this paper
• Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid.

  2017cites this paper
• Complement Activation Induce Blister Formation without Bullous Pemphigoid Autoantibodies Directly

  2017cites this paper
• Biomarkers related to bullous pemphigoid activity and outcome

  2017cites this paper
• Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity

  2017influential citation
• IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants

  2017cites this paper
• Variation of the epidermal expression of glucocorticoid receptor‐beta as potential predictive marker of bullous pemphigoid outcome

  2017cites this paper
• Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid

  2017cites this paper
• Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations

  2017cites this paper
• Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion

  2017cites this paper
• Newer Diagnostic Methods in Detection and Classification of Vesiculo-Bullous Lesions

  2016cites this paper
• IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases

  2016cites this paper
• Serum levels of immunoglobulins G1 and G4 targeting the non‐collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis

  2016cites this paper
• Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid.

  2016cites this paper
• Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.

  2016cites this paper
• Eosinophil localization to the basement membrane zone is autoantibody‐ and complement‐dependent in a human cryosection model of bullous pemphigoid

  2016cites this paper
• Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.

  2016cites this paper
• Anti-BP180-type mucous membrane pemphigoid immunoglobulin G shows heterogeneity of internalization of BP180/collagen XVII into keratinocyte cytoplasm

  2016cites this paper
• IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.

  2016cites this paper
• T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid

  2015cites this paper
• Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid

  2015cites this paper
• Prevalence of pemphigus and pemphigoid autoantibodies in the general population

  2015cites this paper
• IgE autoantibodies in bullous pemphigoid: supporting role, or leading player?

  2015cites this paper
• Bullous Pemphigoid ( BP ) , The Most Common Autoimmune Blistering Disease

  2015cites this paper
• S2k guideline for the diagnosis of pemphigus vulgaris/foliaceus and bullous pemphigoid

  2015cites this paper
• Doxycycline-Inducible Autoimmune Blistering Skin Disease Model

  2015cites this paper
• S2k‐Leitlinie zur Diagnostik des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids

  2015cites this paper
• Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction

  2015cites this paper
• The Role of Pathogenic Autoantibodies in Autoimmunity

  2015cites this paper
• Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.

  2015cites this paper
• Diagnostic accuracy of BP180 NC16a and BP230‐C3 ELISA in serum and saliva of patients with bullous pemphigoid

  2015cites this paper
• Human Eosinophils Express the High Affinity IgE Receptor, FcεRI, in Bullous Pemphigoid

  2014cites this paper
• IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.

  2014cites this paper
• Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation without Complement Activation

  2014cites this paper
• Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII.

  2014cites this paper
• Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida

  2013cites this paper
• Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay.

  2013cites this paper
• B Cells, Dendritic Cells, and Macrophages Are Required To Induce an Autoreactive CD4 Helper T Cell Response in Experimental Epidermolysis Bullosa Acquisita

  2013cites this paper
• Emerging treatments for pemphigoid diseases.

  2013cites this paper
• Malignancy in Relation to Autoimmune Blistering Dermatoses: Molecular and Clinical Aspects

  2013cites this paper
• Clinical immunology Immunoglobulin G4 is prevailing over immunoglobulin G1 in autoimmunity of pemphigus and bullous pemphigoid: analysis of tissue-bound antibodies in active diseases

  2013cites this paper
• Bullöses Pemphigoid

  2013cites this paper
• Mouse models of autoimmune blistering diseases induced by the passive transfer of antibodies.

  2013cites this paper
• AUTOIMMUNE BASEMENT MEMBRANE AND SUBEPIDERMAL BLISTERING DISEASES

  2013cites this paper